Literature DB >> 2011512

Multiple Oct2 isoforms are generated by alternative splicing.

T Wirth1, A Priess, A Annweiler, S Zwilling, B Oeler.   

Abstract

The interaction of the Oct2 transcription factor with the cognate octamer motif ATGCAAAT is a critical determinant of the lymphoid-specific expression of immunoglobulin genes. Ectopic expression of cloned Oct2 cDNA was shown to be sufficient to reconstitute at least some aspects of this regulation in non-lymphoid cells. We describe the isolation and characterization of multiple cDNAs encoding mouse Oct2 from a mature B-cell line and we show that a variety of isoforms of this transcription factor is generated from a single gene by an alternative splicing mechanism. All the isoforms retain the previously characterized POU-domain and are therefore able to bind to the octamer motif. Different amounts of the various isoforms are present within the same B-cell regardless of the developmental stage of B-cell differentiation and at least some of the isoforms are conserved between mouse and humans. In cotransfection experiments we show that all the isoforms are able to activate an octamer containing promoter element in fibroblasts revealing an unexpected functional redundancy. Finally, we show that one of the isoforms encodes the previously described lymphoid-specific Oct2B protein which has been suggested to be involved in the function of the octamer motif in the context of the immunoglobulin heavy-chain (IgH) enhancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011512      PMCID: PMC333532          DOI: 10.1093/nar/19.1.43

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  65 in total

1.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity.

Authors:  T Wirth; L Staudt; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

2.  Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements.

Authors:  R Grosschedl; D Baltimore
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence.

Authors:  J O Mason; G T Williams; M S Neuberger
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

4.  The POU domain is a bipartite DNA-binding structure.

Authors:  R A Sturm; W Herr
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

5.  Isolation of a recombinant copy of the gene encoding C/EBP.

Authors:  W H Landschulz; P F Johnson; E Y Adashi; B J Graves; S L McKnight
Journal:  Genes Dev       Date:  1988-07       Impact factor: 11.361

6.  Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements.

Authors:  F G Falkner; H G Zachau
Journal:  Nature       Date:  1984 Jul 5-11       Impact factor: 49.962

7.  Two regulatory elements for immunoglobulin kappa light chain gene expression.

Authors:  Y Bergman; D Rice; R Grosschedl; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence.

Authors:  T G Parslow; D L Blair; W J Murphy; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  49 in total

1.  The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.

Authors:  X C Li; W L Huang; S J Flint
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

3.  An alternatively spliced Pit-1 isoform altered in its ability to trans-activate.

Authors:  A E Morris; B Kloss; R E McChesney; C Bancroft; L A Chasin
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

4.  Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.

Authors:  A Annweiler; M Müller-Immerglück; T Wirth
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

5.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

6.  A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence.

Authors:  A Annweiler; R A Hipskind; T Wirth
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

7.  Functional modularity in the SP6 kappa promoter.

Authors:  E Högbom; A C Magnusson; T Leanderson
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

8.  Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice.

Authors:  A Annweiler; U Müller; T Wirth
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

9.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

10.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.

Authors:  R J Grumont; J Fecondo; S Gerondakis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.